Literature DB >> 10612440

Antimicrobial activity of polycationic peptides.

A Giacometti1, O Cirioni, F Barchiesi, M S Del Prete, G Scalise.   

Abstract

The in vitro activity of six polycationic peptides, buforin II, cecropin P1, indolicidin, magainin II, nisin, and ranalexin, were evaluated against several clinical isolates of gram-positive and gram-negative aerobic bacteria, yeasts, Pneumocystis carinii and Cryptosporidium parvum, by using microbroth dilution methods. The peptides exhibited different antibacterial activities and rapid time-dependent killing. The gram-negative organisms were more susceptible to buforin II and cecropin P1, whereas buforin II and ranalexin were the most active compounds against the gram-positive strains. Similarly, ranalexin showed the highest activity against Candida spp., whereas magainin II exerted the highest anticryptococcal activity. Finally, the peptides showed high anti-Pneumocystis activity, whereas no compound had strong inhibitory effect on C. parvum.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10612440     DOI: 10.1016/s0196-9781(99)00131-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

2.  Curvularia haloperoxidase: antimicrobial activity and potential application as a surface disinfectant.

Authors:  Eva H Hansen; Line Albertsen; Thomas Schäfer; Charlotte Johansen; Jens C Frisvad; Søren Molin; Lone Gram
Journal:  Appl Environ Microbiol       Date:  2003-08       Impact factor: 4.792

3.  Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.

Authors:  Regina Geitani; Carole Ayoub Moubareck; Lhousseine Touqui; Dolla Karam Sarkis
Journal:  BMC Microbiol       Date:  2019-03-08       Impact factor: 3.605

4.  Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria.

Authors:  Yuling Zhou; Yan Peng
Journal:  Exp Ther Med       Date:  2013-07-23       Impact factor: 2.447

5.  Bombyx mori gloverin A2 alleviates enterotoxigenic Escherichia coli-induced inflammation and intestinal mucosa disruption.

Authors:  Qian Lin; Guoqi Su; Aimin Wu; Daiwen Chen; Bing Yu; Zhiqing Huang; Yuheng Luo; Xiangbing Mao; Ping Zheng; Jie Yu; Junqiu Luo; Jun He
Journal:  Antimicrob Resist Infect Control       Date:  2019-11-26       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.